cidrap.umn1d
Real-world study: RSV vaccine 78% to 80% effective against infection, severe illness in older US veterans
The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...
pulmonologyadvisor1d
FDA Alert: Pulmonology Drug Approvals, Recalls, and Device Updates
FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Medscape4d
RSV Vaccines Will Carry Warning for Guillain-Barré Syndrome
The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...
Axios Vitals on MSN4d
Maternal RSV vaccines found to cut infection risk
Vaccinating pregnant women against RSV reduced the risk of infection in their infants by 61% compared with newborns with ...
After a Reset Year, Is Moderna Stock Poised for a Comeback?
The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.
pulmonologyadvisor4d
RSV Vaccine Labeling Updated With Guillain-Barré Syndrome Warning
The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...
b105country5d
Wisconsin’s 1st Pediatric Flu-Related Death This Year Confirmed
With illness activity high, everyone 6 months and older is urged to get vaccinated against respiratory viruses.